Patent covering the use and pharmaceutical composition of Isofol’s lead Drug candidate, Modufolin®, allowed by United States Patent and Trademark Office

Document -

Patent covering the use and pharmaceutical composition of Isofol’s lead Drug candidate, Modufolin®, allowed by United States Patent and Trademark Office

Isofol patent covering the use and pharmaceutical composition of Modufolin® allowed by the United States Patent and Trademark Office. Isofol provided evidence demonstrating the clear superiority of Modufolin® over folic acid in reducing toxicity resulting from multi-targeting antifolate chemotherapy.
  • License: © All rights reserved
    The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
  • File format: .pdf

Related content

Patent covering the use and pharmaceutical composition of Isofol’s lead Drug candidate, Modufolin®, allowed by United States Patent and Trademark Office

Isofol patent covering the use and pharmaceutical composition of Modufolin® allowed by the United States Patent and Trademark Office. Isofol provided evidence demonstrating the clear superiority of Modufolin® over folic acid in reducing toxicity resulting from multi-targeting antifolate chemotherapy.